These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24522036)

  • 41. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Penson DF
    J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
    [No Abstract]   [Full Text] [Related]  

  • 43. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
    Taneja SS
    J Urol; 2016 May; 195(5):1472. PubMed ID: 27186730
    [No Abstract]   [Full Text] [Related]  

  • 46. Re: variation among primary care physicians in prostate-specific antigen screening of older men.
    Penson DF
    J Urol; 2014 May; 191(5):1291-2. PubMed ID: 24745493
    [No Abstract]   [Full Text] [Related]  

  • 47. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Kuban D; Lee WR; Rosenthal SA; Zietman A; Sandler H; Shipley W; Ritter M; Valicenti R; Catton C; Roach M; Pisansky TM; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):377-82. PubMed ID: 18947941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.
    Shakespeare TP
    Radiat Oncol; 2015 Nov; 10():233. PubMed ID: 26582424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
    Pegurri L; Buglione M; Girelli G; Guarnieri A; Meattini I; Ricardi U; Mangoni M; Gabriele P; Bellavita R; Krengli M; Bonetta A; Cagna E; Bunkheila F; Borghesi S; Signor M; Di Marco A; Bertoni F; Stefanacci M; Gatta R; De Bari B; Magrini SM
    Tumori; 2014; 100(1):31-7. PubMed ID: 24675488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in initial management of prostate cancer in New Hampshire.
    Ingimarsson JP; Celaya MO; Laviolette M; Rees JR; Hyams ES
    Cancer Causes Control; 2015 Jun; 26(6):923-9. PubMed ID: 25840558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. US radiation oncology practice patterns for posttreatment survivor care.
    Koontz BF; Benda R; De Los Santos J; Hoffman KE; Huq MS; Morrell R; Sims A; Stevens S; Yu JB; Chen RC
    Pract Radiat Oncol; 2016; 6(1):50-6. PubMed ID: 26603597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of Radiation Therapy Referral and Utilisation Post-prostatectomy: A Population-based Study of Time Trends.
    Jin CJ; Brundage MD; Cook EF; Miao Q; Hanna TP
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):783-789. PubMed ID: 27461732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
    Alibhai SM; Rahman S; Warde PR; Jewett MA; Jaffer T; Cheung AM
    Urology; 2006 Jul; 68(1):126-31. PubMed ID: 16844454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Albertsen PC; Albertsen PC
    J Urol; 2001 Feb; 165(2):731-2. PubMed ID: 11233050
    [No Abstract]   [Full Text] [Related]  

  • 55. What risk of prostate cancer led urologist to recommend prostate biopsies?
    Roumiguié M; Beauval JB; Bordier B; Filleron T; Rozet F; Ruffion A; Mottet N; Cussenot O; Malavaud B
    Prog Urol; 2015 Dec; 25(16):1125-31. PubMed ID: 26431746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Rickles DJ
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
    [No Abstract]   [Full Text] [Related]  

  • 57. The paradox of multidisciplinary care.
    Potters L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):20-2. PubMed ID: 22901419
    [No Abstract]   [Full Text] [Related]  

  • 58. Variation in prostate cancer care.
    Ghani KR; Miller DC
    JAMA; 2015 May; 313(20):2066-7. PubMed ID: 26010635
    [No Abstract]   [Full Text] [Related]  

  • 59. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiation oncology in Canada.
    Giuliani M; Gospodarowicz M
    Jpn J Clin Oncol; 2018 Jan; 48(1):22-25. PubMed ID: 29077894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.